Cambridge Investment Research Advisors’s Mead Johnson Nutrition Company MJN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q2
Sell
-3,469
Closed -$309K 2009
2017
Q1
$309K Buy
3,469
+162
+5% +$13.3K 0.01% 1359
2016
Q4
$234K Buy
3,307
+376
+13% +$28K ﹤0.01% 1420
2016
Q3
$232K Sell
2,931
-6
-0.2% -$512 ﹤0.01% 1457
2016
Q2
$267K Buy
2,937
+99
+3% +$8.38K 0.01% 1222
2016
Q1
$241K Buy
+2,838
New +$211K 0.01% 1296
2014
Q1
Sell
-2,416
Closed -$202K 1364
2013
Q4
$202K Buy
+2,416
New +$197K 0.01% 1086

Other funds holding MJN

Cambridge Investment Research Advisors's MJN Position: Q2 2017 in Review

Cambridge Investment Research Advisors sold out of Mead Johnson Nutrition Company (MJN) in Q2 2017, closing a stake of 3,469 shares — an estimated $309K sold.

Cambridge Investment Research Advisors first reported a position in MJN in Q4 2013 and held it in 6 quarters. The position peaked at $309K in Q1 2017. 7 funds tracked by Wall St. Rank hold MJN as of Q2 2017.

  • Cambridge Investment Research Advisors reported no remaining Mead Johnson Nutrition Company position as of Q2 2017 after selling out during the quarter.
  • Cambridge Investment Research Advisors sold 3,469 Mead Johnson Nutrition Company shares in Q2 2017, an estimated $309K.
  • Cambridge Investment Research Advisors first reported a position in Mead Johnson Nutrition Company in Q4 2013 and held it in 6 quarters.
  • Cambridge Investment Research Advisors's Mead Johnson Nutrition Company position peaked at $309K in Q1 2017.
  • 7 funds tracked by Wall St. Rank held Mead Johnson Nutrition Company as of Q2 2017.

Based on Cambridge Investment Research Advisors's 13F filing for Q2 2017, filed 8 Aug 2017.